Indapta Therapeutics
Todd A. Fehniger is an Associate Professor in the Department of Medicine (Oncology Division) at the Washington University School of Medicine.
This person is not in the org chart
This person is not in any offices
Indapta Therapeutics
1 followers
Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.